Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Bivalirudin "Nonapprovable" for ACUITY Indication
Link ID 6117
Title Bivalirudin "Nonapprovable" for ACUITY Indication
Url http://www.medscape.com/viewarticle/575211?src=rss
Description The US FDA has issued a "not-approvable" letter to the Medicines Company for an additional dosing regimen of the drug covering upstream treatment of ACS initiated in the emergency department, based on the ACUITY trial. Heartwire
Category Articles > Business of Medicine
Keywords
Date May 29, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Problems With Baxter Heparin Still Unresolved
  Because of continuing severe adverse reactions, Baxter has stopped manufacturing multiple-dose vials of heparin. The FDA is recommending that heparin manufactured by other companies or alternative anticoagulants be used if possible. Medscape Medical News
Category:   Articles > Business of Medicine


2. Enabling Patients to Participate in Self-care Activities After Transferring From the Hospital to the
  The Care Transitions Intervention and the Care Transitions Measure -- currently the only measures of transitional care quality endorsed by the National Quality Forum. Medscape Internal Medicine
Category:   Articles > Business of Medicine


3. Heparin Deaths Higher, FDA Says
  As many as 62 deaths over the past 15 months have been linked to tainted heparin on the basis of allergic/hypotensive symptoms, although heparin may not have actually caused the deaths. Heartwire
Category:   Articles > Business of Medicine


4. AIDS 2008: Care in the Developing World
  New data on the delivery of care in resource-limited countries were presented at the AIDS 2008: XVII International AIDS Conference held August 3-8, 2008, in Mexico City, Mexico. Medscape HIV/AIDS
Category:   Articles > Business of Medicine


5. FDA Approves First Transcranial Magnetic Stimulation Device for Depression
  The FDA has cleared the NeuroStar TMS brain-stimulating device for treating depressed adults for whom one antidepressant has failed to work. WebMD Health News
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS